Displaying 1 - 12 of 16
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Displaying 1 - 12 of 16